Senseera is Transforming the Future of Liquid Biopsy with GEM BIOMARKERS™,a Chromatin Epigenomics Liquid Biopsy Biomarker Discovery Platform

Trojan Bio is an immunotherapy company developing a novel class of therapeutic antibodies for the treatment of a variety of cancers. The company's Trojan antibodies integrate viral peptides to efficiently activate the immune system for cancer eradication.

NOGA Therapeutics is a gene therapy company developing hematopoietic stem cell based gene therapies for rare and common diseases

Emendo biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy. Emendo leverages expertise in protein engineering to bring innovative and disruptive protein tools to resolve the bottlenecks of the field.

Ingenium was a specialized consultancy firm in the field of intellectual property strategy for the biomed sector. According to the CEO’s needs we provided a complete in-house IP management service and tailored a strategic plan for Intellectual property that best served the company’s goals. We provided our clients with clarity regarding their IP position, constructed managerial tools, and provided out of the box solutions for capturing new IP, cost reduction, prosecution optimization and more.

The National Institute for Biotechnology in the Negev (NIBN) was created with a mission to plant the seeds that will lead to the growth of successful biotechnology industries in Israel, particularly in the Negev.

Eventus Diagnostics was a life science company that has developed intellectual property focused on the next generation of cancer diagnostics.